What if you invested $1000 in BSX on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Boston Scientific Corporation has delivered an average annual return of 11.8%. The stock peaked in 2013 with a massive +104.1% gain, while investors faced a downturn in 2008 (-32.2%). Overall, the stock finished in the green 14 times out of 20 years.
Avg Return
+11.8%
Win Rate
70%
14W - 6L
Best
+104.1%
2013
Worst
-32.2%
2008
Performance Consistency
About Boston Scientific Corporation
Visit Website ↗Boston Scientific Corporation is a global medical technology leader that develops, manufactures, and markets innovative medical devices for a wide range of interventional medical specialties. The company's mission is to transform lives through innovative medical solutions that improve the health of patients worldwide.
Key Business Segments
MedSurg
Includes products for endoscopy, urology, and pelvic health.
Rhythm and Neuro
Includes products for cardiac rhythm management, electrophysiology, and neuromodulation.
Cardiovascular
Includes products for interventional cardiology and peripheral interventions.
Key Innovations
- ✓Pioneered medical devices used in angioplasty, making less-invasive procedures more accessible.
- ✓Developed the Taxus Stent, a drug-eluting stent that revolutionized the treatment of clogged arteries.
Historical Milestones
Boston Scientific is founded by John Abele and Peter Nicholas.
The company goes public on the New York Stock Exchange.
The Taxus Stent is launched in the U.S. after FDA approval.